<SEC-DOCUMENT>0000882104-21-000013-index.html : 20210201
<SEC-HEADER>0000882104-21-000013.hdr.sgml : 20210201
<ACCEPTANCE-DATETIME>20210201160315
ACCESSION NUMBER:		0000882104-21-000013
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		1
REFERENCES 429:			333-231870
FILED AS OF DATE:		20210201
DATE AS OF CHANGE:		20210201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PDL BIOPHARMA, INC.
		CENTRAL INDEX KEY:			0000882104
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943023969
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-231870
		FILM NUMBER:		21576707

	BUSINESS ADDRESS:	
		STREET 1:		59 DAMONTE RANCH PARKWAY
		STREET 2:		SUITE B-375
		CITY:			RENO
		STATE:			NV
		ZIP:			89521
		BUSINESS PHONE:		775-832-8500

	MAIL ADDRESS:	
		STREET 1:		59 DAMONTE RANCH PARKWAY
		STREET 2:		SUITE B-375
		CITY:			RENO
		STATE:			NV
		ZIP:			89521

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROTEIN DESIGN LABS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>a20210201s3doc.htm
<DESCRIPTION>POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
<TEXT>
Document 1 - file: a20210201s3doc.htm

</DOCUMENT>
</SEC-DOCUMENT>